Skip to main content
Log in

Effect of a Calcium-Sensitizing Agent, Levosimendan, on the Postcardioplegic Inotropic Response of the Myocardium

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Myocardial contractile function after coronary artery bypass graft surgery is often depressed and may require inotropic support, particularly in patients on treatment with beta-adrenergic and Ca2+ blockers. In view of the increase in cytosolic Ca2+ during early reperfusion, use of Ca2+ sensitizing agents may be preferable to adrenergic agonists for enhancement of contractile function after cardioplegic arrest. The aim of this study was to assess the efficacy of the Ca2+ sensitizer, levosimendan, as an inotrope on the mechanical recovery of hearts after normothermic and hypothermic cardioplegic arrest in the absence and presence of Ca2+ and beta-blockers. Isolated perfused working guinea pig hearts were perfused in the absence or presence of propranolol (10−6 M) and/or nifedipine (10−8 M), subjected to 45 minutes of normothermic or 180 minutes of hypothermic cardioplegic arrest, reperfused, and exposed to increasing concentrations of levosimendan (10−9 to 10−6 M). Levosimendan (10−7 to 10−6 M) has positive inotropic, chronotropic, and vasodilatory effects on normoxic perfused control hearts, as well as during reperfusion after 45 minutes of normothermic cardioplegic arrest. Similar effects were elicited in the presence of the blockers. Levosimendan had no stimulatory effect during reperfusion of hearts subjected to prior hypothermic arrest. Except for the increase in heart rate, the effects of levosimendan on functional performance during reperfusion were comparable with those of adrenaline. Levosimendan elicits a positive inotropic and chronotropic response during reperfusion of hearts after normothermic cardioplegic arrest, both in the absence and presence of Ca2+ and beta-adrenergic blockers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Robson RH, Vishwanath MC. Nifedipine and β-blockade as a cause of cardiac failure. Br Med J 1982;284:104.

    Google Scholar 

  2. Packer MP, Meller J, Medina N, et al. Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man. Circulation 1982;65:660-668.

    Google Scholar 

  3. Packer MP. Combined beta-adrenergic and calcium-entry blockade in angina pectoris. N Engl J Med 1989;320:709-718.

    Google Scholar 

  4. Marban E, Koretsune Y, Corretti M. Calcium and its role in myocardial injury during ischaemia and reperfusion. Circulation 1989;80(Suppl. VI):VI17-VI22.

    Google Scholar 

  5. Du Toit EF, Opie LH. Modulation of the severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at the onset of reperfusion. Circ Res 1992;70: 960-967.

    Google Scholar 

  6. Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki J, Linden I-B. Cardiac troponin-C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 1995;27:1859-1866.

    Google Scholar 

  7. Haikala H, Nissinen E, Etemadzadek E, Levijoki J, Linden I-B. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 1995;25:794-801.

    Google Scholar 

  8. Edes I, Kiss E, Kitada Y, et al. Effect of levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and calcium sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circ Res 1995;77:107-113.

    Google Scholar 

  9. Lancaster MK, Cook SJ. The effects of levosimendan on (Ca2+)i in guinea pig isolated ventricular myocytes. Eur J Pharmacol 1997;339:97-100.

    Google Scholar 

  10. Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N. The novel calcium sensitizer levosimendan activates the ATP-sensitive K+ channel in rat ventricular cells. J Pharmacol Exp Ther 1997;283:375-383.

    Google Scholar 

  11. Gruhn N, Nielsen-Kudsk JE, Theilgaard S, Bang L, Olesen SP, Aldershvile J. Coronary vasorelaxant effect of levosimendan, a new inodilator with calcium-sensitizing properties. J Cardiovasc Pharmacol 1998;31:741-749.

    Google Scholar 

  12. Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N. Levosimendan, a novel Ca2+-sensitizer, activates the glibenclamide-sensitiveK+ channel in rat arterial myocytes. Eur J Pharmacol 1997;333:249-259.

    Google Scholar 

  13. Jamali IN, Kersten JR, Pagel PS, Hettrick DA, Warltier DC. Intracoronary levosimendan enhances contractile function of stunned myocardium. Anesth Analg 1997;85:23-29.

    Google Scholar 

  14. Kannengieser GJ, Opie LH, Van der Werff TJ. Impaired cardiac work and oxygen uptake after reperfusion of regionally ischaemic myocardium. J Mol Cell Cardiol 1979;11:197-207.

    Google Scholar 

  15. Hattingh P, Coetzee A, Harper I, Genade S, Lochner A. Effects of beta-blockers and Ca2+-antagonists on the response of the isolated working rat heart to adrenergic stimulants after cardioplegic arrest. Cardiovasc Drugs Ther 1993;7:851-861.

    Google Scholar 

  16. Boknik P, Neumann J, Kaspareit G, et al. Mechanisms of the contractile effects of levosimendan in the mammalian heart. J Pharmacol Exp Therap 1997;280:277-283.

    Google Scholar 

  17. Sato S, Talukder MA, Sugawara H, Sawada H, Endoh M. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and Indo-1-loaded single ventricular cardiomyocytes of the rabbit. J Mol Cell Cardiol 1998;30:1115-1128.

    Google Scholar 

  18. DiFrancesco D, Mangoni M. Modulation of single hyperpolarization-activated channels (if) by cAMP in rabbit sino-atrial node. J Physiol 1994;474:473-482.

    Google Scholar 

  19. Harkin CP, Pagel PS, Tessmer JP, Warltier DC. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs. J Cardiovasc Pharmacol 1995;26:179-188.

    Google Scholar 

  20. Pagel PS, Harkin CP, Hettrick DA, Warltier DC. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs. J Pharmacol Exp Ther 1995;275:127-135.

    Google Scholar 

  21. Bowman P, Haikala H, Paul RJ. Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization. J Pharmacol Exp Ther 1999;288:316-325.

    Google Scholar 

  22. Soei LK, Sassen LMA, Fan DS. Myofibrillar Ca2+ sensitization predominantly enhances function and mechanical efficiency of stunned myocardium. Circulation 1994;90:959-969.

    Google Scholar 

  23. Lilleberg J, Nieminen MS, Akkila J, et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 1998;19:660-668.

    Google Scholar 

  24. Slogoff S, Keats AS. Randomized trial of primary anesthetic agents on outcome of coronary artery bypass operations. Anesthesiology 1989;70:179-188.

    Google Scholar 

  25. Nayler WG, Ferrari R, Williams A. Protective effect of pretreatment with verapamil, nifedipine and propranolol on myocardial function in the ischaemic and reperfused myocardium. Am J Cardiol 1980;46:242-248.

    Google Scholar 

  26. Mak IT, Weglicki WB. Protection by β-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Circ Res 1988;63:262-266.

    Google Scholar 

  27. Mak IT, Weglicki WB. Comparative anti-oxidant activities of propranolol, nifedipine, verapamil and diltiazem against sarcolemmal membrane lipid peroxidation. Circ Res 1990;66:1449-1452.

    Google Scholar 

  28. Du Toit EF, Muller CA, McCarthy J, Opie LH. Levosimendan: Effects of a calcium sensitizer on function and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff perfused guinea pig heart. J Pharmacol Exp Ther 1999;290:505-514.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lochner, A., Colesky, F. & Genade, S. Effect of a Calcium-Sensitizing Agent, Levosimendan, on the Postcardioplegic Inotropic Response of the Myocardium. Cardiovasc Drugs Ther 14, 271–281 (2000). https://doi.org/10.1023/A:1007878523663

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007878523663

Navigation